1. Wu, Xiwen, Chen, Da, Li, Muqi, Liang, Gehao, Ye, Huizhen. 2024. UCK2 promotes intrahepatic cholangiocarcinoma progression and desensitizes cisplatin treatment by PI3K/AKT/mTOR/autophagic axis. In Cell death discovery, 10, 375. doi:10.1038/s41420-024-02140-x. https://pubmed.ncbi.nlm.nih.gov/39179560/
2. Yu, Youlin, You, Shuqing, Fan, Rengen, Shan, Xiangxiang. 2022. UCK2 regulated by miR-139-3p regulates the progression of hepatocellular carcinoma cells. In Future oncology (London, England), 18, 979-990. doi:10.2217/fon-2021-0271. https://pubmed.ncbi.nlm.nih.gov/35137600/
3. Cai, Jie, Sun, Xuehua, Guo, Han, Kong, Xiaoni, Xia, Qiang. 2020. Non-metabolic role of UCK2 links EGFR-AKT pathway activation to metastasis enhancement in hepatocellular carcinoma. In Oncogenesis, 9, 103. doi:10.1038/s41389-020-00287-7. https://pubmed.ncbi.nlm.nih.gov/33277463/
4. Chen, Erbao, Zou, Zhilin, Wang, Rongyue, Lin, Zewei, Liu, Jikui. 2024. Predictive value of a stemness-based classifier for prognosis and immunotherapy response of hepatocellular carcinoma based on bioinformatics and machine-learning strategies. In Frontiers in immunology, 15, 1244392. doi:10.3389/fimmu.2024.1244392. https://pubmed.ncbi.nlm.nih.gov/38694506/
5. Wu, Dehai, Zhang, Congyi, Liao, Guanqun, Hu, Qiuhui, Tai, Sheng. 2022. Targeting uridine-cytidine kinase 2 induced cell cycle arrest through dual mechanism and could improve the immune response of hepatocellular carcinoma. In Cellular & molecular biology letters, 27, 105. doi:10.1186/s11658-022-00403-y. https://pubmed.ncbi.nlm.nih.gov/36447138/
6. Zhou, Qiming, Jiang, Hai, Zhang, Jianlong, Wang, Jie, Xiao, Zhiyu. 2018. Uridine-cytidine kinase 2 promotes metastasis of hepatocellular carcinoma cells via the Stat3 pathway. In Cancer management and research, 10, 6339-6355. doi:10.2147/CMAR.S182859. https://pubmed.ncbi.nlm.nih.gov/30568496/
7. Yu, Shuo, Li, Xu, Guo, Xingjun, Qin, Renyi, Wang, Ming. 2018. UCK2 upregulation might serve as an indicator of unfavorable prognosis of hepatocellular carcinoma. In IUBMB life, 71, 105-112. doi:10.1002/iub.1941. https://pubmed.ncbi.nlm.nih.gov/30304569/
8. Huang, Shanzhou, Li, Jian, Tam, Nga Lei, He, Xiaoshun, Wu, Linwei. 2019. Uridine-cytidine kinase 2 upregulation predicts poor prognosis of hepatocellular carcinoma and is associated with cancer aggressiveness. In Molecular carcinogenesis, 58, 603-615. doi:10.1002/mc.22954. https://pubmed.ncbi.nlm.nih.gov/30556610/